Update date
16 May 2025
- Info
- Insider Trading
- Financials
NewcelX Ltd. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q2 2025.
- Symbol
- NCEL on Nasdaq
- Location
- Zurich
- Fiscal year end
- 31 December
- Latest financial report
- 16 May 2025
Shareable Research Card
NCEL - NewcelX Ltd. Financial Facts
NCEL - NewcelX Ltd. has a source-backed company facts page for reviewing reported financial metrics, periods, and linked metric histories.
Start with the latest metric summary, then open metric histories or cross-company rankings to compare the same SEC-backed facts.
- Context
- Latest metrics period: Q2 2025
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Return Loop
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q2 2025
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q2 2025.
- Most recent SEC facts end date on this page: 30 Jun 2025.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for NCEL - NewcelX Ltd.
Latest financial period: Q4 2024. Reopen this facts page to verify the newest reported period against the prior baseline.
Page type
Company facts
Latest period
Q2 2025
SEC-backed company facts were refreshed from filings filed on 16 May 2025.
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Quick Takeaways
- NCEL - NewcelX Ltd. financial facts are built from SEC company filings data.
- Latest metrics period on this page: Q2 2025.
- Headline metric summary will appear when SEC facts are available.
What Changed
- No metrics are currently available for comparison on this facts page.
- Changes will populate automatically as new 10-Q/10-K periods are processed.
Why This Matters
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Every metric card links to a deeper SEC-backed history page for verification.
Source Evidence
Based on latest 10-Q/10-K
See Original Filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
n/a
Insufficient Data Confidence low
Financial Health
Share Metrics
| Metric | Latest value | YoY change |
|---|---|---|
| Common Stock, Shares, Outstanding | 4,152,056 | +321% |
| Common Stock, Value, Issued | $153,141 | -81% |
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY change |
|---|---|---|
| Accounts Payable, Current | $1,021,052 | -78% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $108,853 | +2487% |
| Additional Paid in Capital | $77,361,856 | |
| Assets | $4,337,628 | +263% |
| Assets, Current | $4,035,887 | +238% |
| Cash and Cash Equivalents, at Carrying Value | $3,072,376 | +456% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $3,072,376 | +456% |
| Common Stock, Par or Stated Value Per Share | 0.04 | |
| Common Stock, Shares, Issued | 4,152,056 | +321% |
| Liabilities | $1,455,121 | -86% |
| Liabilities and Equity | $4,337,628 | +263% |
| Other Assets, Noncurrent | $283 | |
| Preferred Stock, Par or Stated Value Per Share | 0.04 | |
| Preferred Stock, Shares Issued | 1,249,904 | |
| Preferred Stock, Shares Outstanding | 1,249,904 | |
| Property, Plant and Equipment, Net | $5,303 | +436% |
| Retained Earnings (Accumulated Deficit) | $74,805,306 | -3.3% |
| Stockholders' Equity Attributable to Parent | $2,882,507 |
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY